| Pharmaceutical Information |
| Drug Name |
Sucralfate |
| Drug ID |
BADD_D02081 |
| Description |
Sucralfate is a medication that is widely used to prevent and treat a number of diseases in the gastrointestinal tract such as duodenal ulcers [FDA label], gastro-esophageal reflux disease (GERD), gastritis, peptic ulcer disease, stress ulcer, in addition to dyspepsia [A177655]. It is considered a _cytoprotective agent_, protecting cells in the gastrointestinal tract from damage caused by agents such as gastric acid, bile salts, alcohol, and acetylsalicylic acid (aspirin), among other substances [A177655, F4519].
Sucralfate has been shown to be a well-tolerated and safe drug. It is sold under many brands and is available in both tablet and suspension forms. It was approved by the FDA 1982 in tablet form, and in 1994 for the suspension form [L6073, L6076]. |
| Indications and Usage |
The sucralfate suspension [FDA label] and tablet [F4534] are used for the treatment of active duodenal ulcer for up to 8 weeks. The tablet form may be used at a lower dose for healed duodenal ulcers, for the purpose of maintaining healing and preventing recurrence [F4519, F4534].
Sucralfate is also used in the prevention and/or treatment of gastro-esophageal reflux disease (GERD), gastritis, peptic ulcer disease, stress ulcer, in addition to dyspepsia [A177655, F4519]. |
| Marketing Status |
approved |
| ATC Code |
A02BX02 |
| DrugBank ID |
DB00364
|
| KEGG ID |
D00446
|
| MeSH ID |
D013392
|
| PubChem ID |
121494085
|
| TTD Drug ID |
D06ULU
|
| NDC Product Code |
38779-0318; 69984-001; 58914-170; 60687-738; 63739-193; 72189-234; 50090-5287; 62135-436; 55512-0002; 17856-1011; 0093-2210; 70771-1833; 0615-4517; 63629-1307; 63629-9152; 0378-9205; 70934-525; 0395-8155; 38779-3219; 49452-7401; 62991-1148; 69238-1656; 71335-2114; 71610-541; 10695-162; 0904-7269; 55512-0020; 55603-225; 55603-611; 59762-0401; 63629-9153; 68094-043; 80425-0091; 55512-0009; 51655-031; 58914-171; 66689-305; 68788-8946; 70518-0775; 72189-429; 80425-0213; 55512-0019; 55603-215; 66039-946; 29033-003; 60687-695; 69339-148; 80425-0188; 10695-091; 55512-0021; 58914-172; 0121-0974; 51079-753; 53002-4930; 55154-5790; 68788-8316; 70518-3690; 72578-081; 51655-475; 55154-4379; 63739-943; 71610-017; 51552-0039; 55603-805; 50090-6455; 0254-1011 |
| UNII |
XX73205DH5
|
| Synonyms |
Sucralfate | Aluminum Sucrose Sulfate | Sulfate, Aluminum Sucrose | Basic Aluminum Sucrose Sulfate | Ulsanic | Ulcerban | Ulcogant | Antepsin | Carafate |
|
| Chemical Information |
| Molecular Formula |
C12H54Al9O55S8 |
| CAS Registry Number |
54182-58-0 |
| SMILES |
C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS
(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.
O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
